Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB16925ApprovedWithdrawnVaccines
Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (UV, formaldehyde inactivated) is a component of an inactivated influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses.
- First approval
- United States, 2022
Resolves to
Compound
What you can answer from here — as of July 08, 2025
Which companies are running trials of Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (UV, formaldehyde inactivated), in which indications and phases, and which of those programs are still active?